Linda M. Richardson - 15 Nov 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
EVP & Chief Commercial Officer
Signature
/s/ Jared Freedberg, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
-$3,022
Form type
4
Filing time
17 Nov 2021, 06:00:39 UTC
Previous filing
03 Sep 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $3,022 -171 -0.67% $17.67 25,533 15 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.